Bumex and Failure to thrive - a phase IV clinical study of FDA data

Summary:

Failure to thrive is reported as a side effect among people who take Bumex (bumetanide), especially for people who are male, 60+ old, also take Coreg, and have Myelodysplastic syndrome.

The phase IV clinical study analyzes which people have Failure to thrive when taking Bumex. It is created by eHealthMe based on reports of 9,078 people who have side effects when taking Bumex from the FDA, and is updated regularly.

What is Bumex?

Bumex has active ingredients of bumetanide. It is often used in swelling. eHealthMe is studying from 9,210 Bumex users. Check the latest studies of Bumex.

What is Failure to thrive?

Failure to thrive (inadequate weight gain and physical growth in children) is found to be associated with 771 drugs and 1,168 conditions by eHealthMe. Check the latest studies of Failure to thrive.

On Jul, 10, 2026

9,078 people reported to have side effects when taking Bumex.
Among them, 23 people (0.25%) have Failure to thrive.

Among these 23 people:

What is the gender of people who have Failure to thrive when taking Bumex? *

female: 14.29 %
male: 85.71 %

What is the age of people who have Failure to thrive when taking Bumex? *

What are other drugs people take besides Bumex? *

What are other side effects people have besides Failure to thrive? *

Weakness: 11 people, 47.83%
Fatigue (feeling of tiredness): 9 people, 39.13%
Acute Kidney Failure: 9 people, 39.13%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 8 people, 34.78%
Nausea (feeling of having an urge to vomit): 8 people, 34.78%
Blood Creatinine Increased: 8 people, 34.78%
Nausea And Vomiting: 8 people, 34.78%
Urine Output Decreased: 7 people, 30.43%
Blood Urea Increased: 6 people, 26.09%
Haemoglobin Decreased: 5 people, 21.74%

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 8 people, 34.78%
Iron Overload: 5 people, 21.74%
Multiple Myeloma (cancer of the plasma cells): 3 people, 13.04%
Renal Cell Carcinoma (a kidney cancer): 2 people, 8.70%
Pain: 2 people, 8.70%
Blood Iron Increased: 2 people, 8.70%
Nausea (feeling of having an urge to vomit): 1 person, 4.35%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 1 person, 4.35%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 4.35%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Bumex and have Failure to thrive?

- Check whether Failure to thrive is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bumex:

Bumex (9,210 reports)

Browse all side effects of Bumex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Failure to thrive:

Failure to thrive (771 drugs)

Browse all the conditions that are associated with Failure to thrive:

Failure to thrive (1,168 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bumetanide (the active ingredients of Bumex) and Bumex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.